Edward Rocnik

Edward Rocnik is the Vice President, Global Head of CMC at HiFiBiO Therapeutics. He is a seasoned scientist with over 12 years of experience in CMC and research-related roles.

Previously, Dr. Rocnik has held various CMC and research roles at Takeda, Millennium, and Organogenesis. Most recently, he served as Director, Head of Late-Stage Analytical Development, Cell Therapies at Takeda.

Dr. Rocnik earned his Ph.D. and BS from Western University.